Developing a new tool to visualize dopamine receptors in the brain
Novel tool development for quantitative PharmacoSTORM super-resolution imaging of the nanoscale distribution of D3 dopamine receptors
This study is working on a new imaging tool to help scientists see how dopamine receptors in the brain are spread out, which could lead to better treatments for mental health and substance use issues.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Trustees of Indiana University NIH-funded |
| Lab location | 1 site (Bloomington, United States) |
| Project ID | NIH-10670438 on NIH RePORTER |
What this research studies
This research focuses on creating an innovative imaging tool that allows scientists to observe the distribution of D3 dopamine receptors at a nanoscale level in the brain. By using advanced super-resolution imaging techniques, the study aims to enhance our understanding of how these receptors function in relation to mental health and substance use disorders. The goal is to uncover the complex mechanisms behind these conditions, which could lead to the development of more effective treatments. Patients may benefit from improved therapies targeting the dopaminergic system, which is crucial for managing various psychiatric disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults suffering from mental health disorders or substance use disorders.
Not a fit: Patients with no mental health or substance use disorders may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for mental health and substance use disorders.
How similar studies have performed: Previous research has shown promise in using advanced imaging techniques to study brain receptors, indicating potential success for this novel approach.
Where this research is happening
Bloomington, United States
- Trustees of Indiana University — Bloomington, United States (Active)
Researchers
- Principal investigator: Katona, Istvan — Trustees of Indiana University
- Study coordinator: Katona, Istvan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.